Newsroom

PARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, announced today that Chief Medical Officer Dr. Jamie Oliver, Pharm.D., will participate as a panelist at BioFuture 2026, taking place Oct. 27-28, 2026, in New York. Dr. Oliver will join fellow industry leaders to discuss the technologies shaping what comes next across the life sciences, including oncology, CNS,...

LOS ANGELES--(BUSINESS WIRE)--Paris Hilton, through her nonprofit 11:11 Media Impact and presented by Loop Earplugs, brought together more than 200 neurodivergent creators with a combined audience reach of 500 million+, along with advocates and experts, for UNSTOPPABLE, a first-of-its-kind ADHD creator summit held at Slivington Manor in Los Angeles on October 15. The daylong event featured interactive activations, educational sessions, and candid conversations designed to build community and eq...

PHOENIX--(BUSINESS WIRE)--EmeraNovaTM, the new corporate identity of BioLab Holdings and a medical technology company building an advanced tissue restoration platform, is expanding its tissue preparation and restorative capabilities through a new commercialization collaboration with Hyalomatrix®.Hyalomatrix is a regenerative matrix built on hyaluronic acid technology to support tissue regeneration and complex wound healing. The technology joins EmeraNova’s growing toolbox of solutions designed t...

WASHINGTON--(BUSINESS WIRE)--A cross-practice team at Sterne, Kessler, Goldstein & Fox served as U.S. International Trade Commission and Federal Circuit counsel to Netlist, Inc. in a series of patent disputes with Micron Technology, Inc. After several years of litigation, Netlist has reached a comprehensive settlement agreement with Micron. Under the agreements, Micron will receive a five-year term license to Netlist’s patent portfolio, including patents covering server DIMMs and High Bandw...

BARCELONA, España--(BUSINESS WIRE)--Smadex, una plataforma líder en publicidad orientada a resultados que ayuda a los anunciantes de aplicaciones más importantes de la industria a impulsar su crecimiento en los sectores de los dispositivos móviles y la televisión conectada (CTV), anunció hoy el nombramiento de Luis de la Cámara como director de Marketing. De la Cámara se incorpora a Smadex, la unidad de compra programática de Entravision, tras cinco años en Rovio Entertainment (SEGA), la compañ...

LONDON--(BUSINESS WIRE)--  Re: ARRAN RESIDENTIAL MORTGAGE A2B 144A   EUR           .00   MATURING: 20-Oct-2048   ISIN: XS0685394552     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Oct-2026 TO 20-Jan-2027 HAS BEEN FIXED AT 5.74 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 20-Jan-2027 WILL AMOUNT TO: EUR        .0  PER EUR      .00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Nationwide Building Society.   GBP  600,000,000.00   MATURING: 22-Jan-2027   ISIN: XS2443513440     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Jul-2026 TO 22-Oct-2026 HAS BEEN FIXED AT 4.03 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 22-Oct-2026 WILL AMOUNT TO: GBP      10.15 PER GBP  1,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: European Bank For Reconstruction And Development   USD 700,000,000.00   MATURING: 20-Apr-2028   ISIN: XS2589240451     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 24-Jul-2026 TO 23-Oct-2026 HAS BEEN FIXED AT 4.15 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 23-Oct-2026 WILL AMOUNT TO: USD 10.48 PER USD 1,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Nationwide Building Society.   GBP 500,000,000.00   MATURING: 24-Jan-2028   ISIN: XS2988672650     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Jul-2026 TO 22-Oct-2026 HAS BEEN FIXED AT 4.28 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 22-Oct-2026 WILL AMOUNT TO: GBP 10.78 PER GBP 1,000.00 DENOMINATION  ...

NEW YORK--(BUSINESS WIRE)--KBRA releases research examining the performance of 2012-16 vintage commercial mortgage-backed securities (CMBS) conduit transactions as they approach the end of their life cycles, with a focus on transaction tail periods, principal paydowns and losses, and interest payment disruptions as the remaining underlying loans mature and undergo workouts. CMBS conduit securitizations issued from 2012 through 2016 were predominantly collateralized by 10-year loans, most of whi...